MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, CPRX made $588,989K in revenue. $214,262K in net income. Net profit margin of 36.38%.

Income Overview

Revenue
$588,989K
Net Income
$214,262K
Net Profit Margin
36.38%
EPS
$1.68
Unit: Thousand (K) dollars
Revenue Breakdown
    • Firdapse
    • Agamree
    • Fycompa
    • License And Other Revenue

Income Statement
2025-12-31
Total revenues
588,989
Cost of sales
87,253
Research and development
12,709
Selling, general and administrative
193,751
Amortization of intangible assets
37,498
Total operating costs and expenses
331,211
Operating income
257,778
Other income, net
25,737
Net income before income taxes
283,515
Income tax provision
69,189
Net income
214,326
Unrealized gain (loss) on available-for-sale securities, net of tax of 0, (20) and 4, respectively
-64
Comprehensive income
214,262
Basic EPS
1.75
Diluted EPS
1.68
Basic Average Shares
122,290,866
Diluted Average Shares
127,257,929
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Firdapse$358,380K Agamree$117,086K Fycompa$113,341K Product Revenue Net$588,807K License And OtherRevenue$182K Total revenues$588,989K Operating income$257,778K Other income, net$25,737K Total operating costsand expenses$331,211K Net income beforeincome taxes$283,515K Selling, general andadministrative$193,751K Cost of sales$87,253K Amortization of intangibleassets$37,498K Research and development$12,709K Net income$214,326K Income tax provision$69,189K Comprehensive income$214,262K Unrealized gain (loss) onavailable-for-sale securities, net...-$64K

CATALYST PHARMACEUTICALS, INC. (CPRX)

CATALYST PHARMACEUTICALS, INC. (CPRX)